In vitro embryotoxicity of carbamazepine and carbamazepine-10,11-epoxide

Teratology

Volumn 54, Issue 1, 1996, Pages 45-51

  Hansen, Deborah K ^a   Dial, Stacey L ^a   Terry, Ketti K ^a   Grafton, Thomas F ^a  

^a NATIONAL CENTER FOR TOXICOLOGICAL RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; CARBAMAZEPINE 10,11 OXIDE; DRUG METABOLITE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; EMBRYO; EMBRYO CULTURE; EMBRYOTOXICITY; MOUSE; NEURAL TUBE DEFECT; NONHUMAN; PRIORITY JOURNAL; RAT; SPECIES DIFFERENCE;

ANIMALS; CARBAMAZEPINE; MICE; RATS; TERATOGENS;

ANIMALIA; RODENTIA;

EID: 0029952068     PISSN: 00403709     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9926(199607)54:1<45::AID-TERA6>3.0.CO;2-2     Document Type: Article

References (42)

1. Brown, N.A., and S. Fabro (1981) Quantitation of rat embryonic development in vitro: A morphological scoring system. Teratology, 24:65-78.
2. Dansky, L.V., and R.H. Finnell (1991) Parental epilepsy, anticonvulstant drugs, and reproductive outcome: Epidemiological and experimental finding spanning three decades. 2. Human studies. Reprod. Toxicol., 5:301-335.
3. Eichelbaum, M., T. Tomson, G. Tybring, and L. Bertilsson (1985) Carbamazepine metabolism in man. Induction and pharmacogenetic aspects. Clin. Pharmacokinet., 10:80-90.
4. Eluma, F.O., M.E. Sucheston, T.G. Hayes, and R.B. Paulson (1984) Teratogenic effects of dosage levels and time of administration of carbamazepine, sodium valproate, and diphenylhydantoin on craniofacial development in the CD-1 mouse fetus. J. Craniofac. Genet. Dev. Biol., 4:191-210.
5. Finnell, R.H., V.K. Mohl, G.D. Bennett, and S.M. Taylor (1986) Failure of epoxide formation to influence carbamazepine-induced teratogenesis in a mouse model. Teratogen. Carcinogen. Mutagen., 6:393-401.
6. Fujinaga, M., and J.M. Baden (1992) Variation in development of rat embryos at the presomite period. Teratology, 45:661-670.
7. Gladstone, D.J., M. Bologa, C. Maguire, A. Pastuszak, and G. Koren (1992) Course of pregnancy and fetal outcome following maternal exposure to carbamazepine and phenytoin: A prospective study. Reprod. Toxicol., 6:257-261.
8. Grafton, T.F., J.J. Bazare Jr., D.K. Hansen, and D.M. Sheehan (1987) The in vitro embryotoxicity of 5-fluorouracil in rat embryos. Teratology, 36:371-377.
9. Hiilesmaa, V.K., K. Teramo, M.-L. Granström, and A.H. Bardy (1981) Fetal head growth retardation associated with maternal antiepileptic drugs. Lancet, 2:165-167.
10. Jones, K.L., R.V. Lacro, K.A. Johnson, and J. Adams (1989) Pattern of malformations in the children of women treated with carbamazepine during pregnancy. N. Engl. J. Med., 320:1661-1666.
11. Juchau, M.R. (1989) Bioactivation in chemical teratogenesis. Annu. Rev. Pharmacol. Toxicol., 29:165-187.
12. Källén, B. (1986) A register study of maternal epilepsy and delivery outcome with special reference to drug use. Acta Neurol. Scand., 73:253-259.
13. Källén, A.J.B. (1994) Maternal carbamazepine and infant spina bifida. Reprod. Toxicol., 8:203-205.
14. Kaneko, S., K. Otani, Y. Fukushima, Y. Ogawa, Y. Nomura, T. Ono, Y. Nakane, T. Teranishi, and M. Goto (1988) Teratogenicity of antiepileptic drugs: Analysis of possible risk factors. Epilepsia, 29: 459-467.
15. Kerr, B.M., K.E. Thummel, C.J. Wurden, S.M. Klein, D.L. Kroetz, F.J. Gonzalez, and R.H. Levy (1994) Human liver carbamazepine metabolism. Role of cyp3A4 and cyp2C8 in 10,11-epoxide formation. Biochem. Pharmacol., 47:1969-1979.
16. Kubow, S., and P.G. Wells (1989) In vitro bioactivation of phenytoin to a reactive free radical intermediate by prostaglandin synthetase, horseradish peroxidase, and thyroid peroxidase. Mol. Pharmacol., 35:504-511.
17. Labarca, C., and K. Paigen (1980) A simple, rapid, and sensitive DNA assay procedure. Anal. Biochem., 102:344-352.
18. Lertratanangkoon, K., and M.G. Horning (1982) Metabolism of carbamazepine. Drug Metab. Disp., 10:1-10.
19. Lindhout, D., R.J.E.A, Höppener, and H. Meinardi (1984) Teratogenicity of antiepileptic drug combinations with special emphasis on epoxidation (of carbamazepine). Epilepsia, 25:77-83.
20. Little, B.B., R. Santos-Ramos, J.F. Newell, and M.C. Maberry (1993) Megadose carbamazepine during the period of neural tube closure. Obstet. Gynecol., 82:705-708.
21. Miranda, A.F., M.J. Wiley, and P.G. Wells (1994) Evidence for embryonic peroxidase-catalyzed bioactivation and glutathione-dependent cytoprotection in phenytoin teratogenicity: Modulation by eicosatetraynoic acid and buthionine sulfoximine in murine embryo culture. Toxicol. Appl. Pharmacol., 124:230-241.
22. Nakane, Y., T. Okuma, R. Takahashi, Y. Sato, T. Wada, T. Sato, Y. Fukushima, H. Kazamatsuri, M. Inami, S. Komai, M. Seino, M. Miyakoshi, T. Tanimura, H. Hazama, R. Kawahara, S. Otsuki, K. Hosokawa, K. Inanaga, Y. Nakazawa, and K. Yamamoto (1980) Multi-institutional study on the teratogenicity and fetal toxicity of antiepileptic drugs: A report of a collaborative study group in Japan. Epilepsia, 21:663-680.
23. National Institutes of Health (1985) Guide for the Care and Use of Laboratory Animals. NIH Publ. 85-23.
24. New, D.A.T. (1978) Whole embryo culture and the study of mammalian embryos during organogenesis. Biol. Rev., 53:81-122.
25. Niebyl, J.R., D.A. Blake, J.M. Freeman, and R.D. Luff (1979) Carbamazepine levels in pregnancy and lactation. Obstet. Gynecol., 53:139-140.
26. Omtzigt, J.G.C., F.J. Los, J.W.A. Meijer, and D. Lindhout (1993) The 10,11-epoxide-10,11-diol pathway of carbamazepine in early pregnancy in maternal serum, urine, and amniotic fluid: Effect of dose, comedication, and relation to outcome of pregnancy. Ther. Drug Monit., 15:1-10.
27. Paulson, R.B., G.W. Paulson, and S. Jreissaty (1979) Phenytoin and carbamazepine in production of cleft palates in mice. Arch. Neurol., 36:832-836.
28. Pienimäki, P., A.-L. Hartikainen, P. Arvela, T. Partanen, R. Herva, O. Pelkonen, and K. Vähäkangas (1995) Carbamazepine and its metabolites in human perfused placenta and in maternal and cord blood. Epilepsie, 36:241-248.
29. Rosa, F.W. (1991) Spina bifida in infants of women treated with carbamazepine during pregnancy. N. Engl. J. Med., 324:674-677.
30. Schardein, J.L. (1993) "Anticonvulsants" In: Chemically Induced Birth Defects. Marcel Dekker, New York, pp. 157-207.
31. Scialli, A.R., and A. Lione (1989) Teratogenic effects of carbamazepine. N. Engl. J. Med., 321:1480-1481.
32. Scolnik, D., I. Nulman, J. Rovet, D. Gladstone, D. Czuchta, H.A. Gardner, R. Gladstone, P. Ashby, R. Weksberg, T. Einarson, and G. Koren (1994) Neurodevelopment of children exposed in utero to phenytoin and carbamazepine monotherapy. JAMA, 271:767-770.
33. Sillanpää, M. (1993) "Carbamazepine" In: The Treatment of Epilepsy: Principles and Practices. E. Wyllie, ed. Lea & Febiger, Philadelphia, pp. 867-886.
34. Sokal, R.R. and F.J. Rohlf (1969) Biometry. W.H. Freeman, San Francisco.
35. Sullivan, F.M., and P.R. McElhatton (1977) A comparison of the teratogenic activity of the antiepileptic drugs carbamazepine, clonazepam, ethosuximide, phenobarbital, phenytoin, and primidone in mice. Toxicol. Appl. Pharmacol., 40:365-378.
36. Taylor, S.M., G.D. Bennett, L.C. Abbott, and R.H. Finnell (1985) Seizure control following administration of anticonvulsant drugs in the quaking mouse. Eur. J. Pharmacol., 118:163-170.
37. Tomson, T., U. Lindbom, B. Ekqvist, and A. Sundqvist (1994) Disposition of carbamazepine and phenytoin in pregnancy. Epilepsia, 35: 131-135.
38. Vorhees, C.V., K.D. Acuff, W.P. Weisenburger, and D.R. Minck (1990) Teratogenicity of carbamazepine in rats. Teratology, 41:311-317.
39. Wells, P.G., M.K. Nagai, and G.S. Greco (1989a) Inhibition of trimethadione and dimethadione teratogenicity by the cyclooxygenase inhibitor acetylsalicylic acid: A unifying hypothesis for the teratogenic effects of hydantoin anticonvulsants and structurally related compounds. Toxicol. Appl. Pharmacol., 97:406-414.
40. Wells, P.G., J.T. Zubovits, S.T. Wong, L.M. Molinari, and S. Ali (1989b) Modulation of phenytoin teratogenicity and embryonic covalent binding by acetylsalicylic acid, caffeic acid, and α-phenyl-N-t-butylnitrone: Implications for bioactivation by prostaglandin synthetase. Toxicol. Appl. Pharmacol., 97:192-202.
41. Wilder, B.J. (1992) Pharmacokinetics of valproate and carbamazepine. J. Clin. Psychopharmacol., 12:564-568.
42. Wrighton, S.A., and J.C. Stevens (1992) The human hepatic cytochromes P450 involved in drug metabolism. Crit. Rev. Toxicol., 22:1-21.